Plasma variations in stress markers: clinical trial of two anesthetics used in regional block in the extraction of impacted inferior third molars by Arteagoitia Calvo, María Iciar et al.
Med Oral Patol Oral Cir Bucal. 2014 May 1;19 (3):e274-9.                                                                                                                        Stress markets: comparative study between two anesthetics
e274
Journal section: Oral Surgery
Publication Types: Research
Plasma variations in stress markers: Clinical trial of two anesthetics used in 
regional block in the extraction of impacted inferior third molars
Iciar Arteagoitia 1, Mercedes Zumarraga 2, Ricardo Dávila 2, Luis Barbier 3, Gorka Santamaría 4, Joseba 
Santamaria 3
1 Stomatology I Department, University of the Basque Country, UPV/EHU, Bizkaia, Spain, Grupo de Alto Rendimiento Acadé-
mico UPV/EHU IT821-13
2 Research Department of Neurochemistry, Bizkaia Mental Health Network, Basque Health Service-Osakidetza, Zamudio Hos-
pital, Bizkaia, Spain
3 Maxillofacial Surgery Department, BioCruces Health Research Institute, Cruces University Hospital, Bizkaia, Spain. Stomato-
logy I Department, UPV/EHU, Grupo de Alto Rendimiento Académico IT821-13
4 Private Practice. Postgraduate Professor, University of the Basque Country, UPV/EHU
Correspondence:
Hospital Universitario Cruces
Gurutzetako Unibertsitate Ospitalea 
Plaza de Cruces s/n 48903 
Barakaldo, Bizkaia, Spain
jsz@clinicaimd.com
Received: 03/06/2013
Accepted: 26/09/2013
Abstract
Objectives: Was to evaluate the effect of different regional anesthetics (articaine with epinephrine versus prilo-
caine with felypressin) on stress in the extraction of impacted lower third molars in healthy subjects. 
Sutdy Desing: A prospective single-blind, split-mouth cross-over randomized study was designed, with a control 
group. The experimental group consisted of 24 otherwise healthy male volunteers, with two impacted lower third 
molars which were surgically extracted after inferior alveolar nerve block (regional anesthesia), with a fortnight’s 
interval: the right using 4% articaine with 1:100.000 epinephrine, and the left 3% prilocaine with 1:1.850.000 fely-
pressin. Patients were randomized for the first surgical procedure. To analyze the variation in four stress markers, 
homovanillic acid, 3-methoxy-4-hydroxyphenylglycol, prolactin and cortisol, 10-mL blood samples were obtained at 
t = 0, 5, 60, and 120 minutes. The control group consisted of 12 healthy volunteers, who did not undergo either extrac-
tions or anesthetic procedures but from whom blood samples were collected and analyzed in the same way. 
Results: Plasma cortisol increased in the experimental group (multiple range test, P<0.05), the levels being sig-
nificantly higher in the group receiving 3% prilocaine with 1:1.850,000 felypressin (signed rank test, p<0.0007). 
There was a significant reduction in homovanillic acid over time in both groups (multiple range test, P<0.05). No 
significant differences were observed in homovanillic acid, 3-methoxy-4-hydroxyphenylglycol or prolactin con-
centrations between the experimental and control groups. 
Conclusions: The effect of regional anesthesia on stress is lower when 4% articaine with 1:100,000  epinephrine 
is used in this surgical procedure.
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Introduction
Local and regional anesthetics are believed to be the 
drugs most frequently used in dentistry. It has been 
estimated that about 1,500 cartridges of anesthetic are 
used per dentist per year. Extrapolating this to dentists 
worldwide suggests that anesthetic block in dental clin-
ics is probably the most widely used anesthetic tech-
nique for oral surgical procedures. For this, 4% artic-
aine with 1:100,000 epinephrine and 3% prilocaine with 
1:1.850.000 felypressin are among the most frequently 
used agents. Monitoring by drug control agencies indi-
cates that these drugs can be used safely and effectively 
(1). Little is known, however, about their effect on levels 
of patient stress. 
We selected extraction of impacted inferior third molars 
as the surgical technique in which to assess the varia-
tions in plasma levels of four stress markers: homova-
nillic acid (p-HVA); 3-methoxy-4-hydroxyphenylglycol 
(p-MHPG); prolactin (p-prolactin) and cortisol (p-cor-
tisol). In controlled experimental conditions, p-HVA is 
the most reliable indicator of central dopaminergic ac-
tivity in plasma (2-5); while p-MHPG is the main plas-
matic norepinephrine metabolite and reflects peripheral 
noradrenergic activity (4). Levels of p-prolactin vary 
as a consequence of physical and psychological stress; 
furthermore, it is an indirect measurement of dopamin-
ergic activity (3-5). Lastly, p-cortisol indicates hypoth-
alamic-pituitary-adrenal-axe activity, which undergoes 
alterations in situations of stress (4,6).
The objective of this study was to clinically assess the 
effect of regional anesthetic block on stress levels. For 
this, we used two different vasoconstrictors in combi-
nation with an anesthetic (4% articaine with 1:100,000 
epinephrine and 3% prilocaine with 1:1.850,000 fely-
pressin) on levels of p-HVA, p-MHPG, prolactin, and 
cortisol in the extraction of impacted inferior third mo-
lars in otherwise healthy subjects.
Material and Methods
We designed a prospective single-blind, split-mouth 
cross-over randomized study, with a control group. The 
study was performed in accordance with the Declaration 
of Helsinki and the International Conference on Good 
Clinical Practice. The study protocol and informed con-
sent forms were approved by Cruces Ethics Committee. 
All subjects were fully informed of the nature of the 
research, and gave their written consent to participate 
in the study. A registration number for this study is not 
available as it was designed before the enactment of the 
International Committee of Medical Journal Editors 
Guidelines.
We tested the null hypothesis that lower third molar exo-
dontias cause no variations on serum markers of stress. If 
the null hypothesis is rejected we test whether both anes-
thetics have the same effect on serum stress markers.
The eligible population was all patients referred to the 
Department of Oral and Maxillofacial Surgery at Cruc-
es University Hospital for the extraction of two impact-
ed lower third molars with inferior alveolar nerve block 
(regional anesthesia). Inclusion criteria were: being a 
man between 18 and 25 years old, who was a non-smok-
er and had taken no medication in the previous month, 
with two lower third molars completely covered by mu-
cosa and partially by bone.
The experimental group (EG) consisted of 24 other-
wise healthy male volunteers, in the required age range 
(x=20.67 years; SD=1.84), with two lower third molars 
totally covered by mucosa and partially by bone that 
were subsequently surgically extracted under inferior 
alveolar nerve block anesthesia. These 24 patients were 
recruited and underwent surgery consecutively. They 
had their two lower third molars extracted a fortnight 
apart, the right lower third molar being extracted using 
4% articaine with 1:100,000 epinephrine, and the left 
lower third molar using 3% prilocaine with 1:1.850,000 
felypressin. The patients were randomized for the first 
surgical procedure. The control group (CG) consisted 
of 12 healthy male volunteers in the same age range (x= 
21.03 years; SD=1.95). This group did not undergo ei-
ther lower third molar extractions or anesthetic proce-
dures; however, blood samples were collected on two 
occasions a fortnight apart (hereon, day 1 and day 2). 
The setting and procedure for obtaining the blood 
samples were the same for both the experimental and 
control groups. The procedure commenced at the same 
time, 8.30 a.m., the participants having fasted since 12 
p.m. the previous night. Venipuncture was performed, 
inserting a permanent catheter in the radial vein of the 
left arm. Once inserted, a 10-mL blood sample (t0´) was 
collected in a Vacutainer® tube. 
The patients in the EG were immediately anesthetized 
to block the lower dental nerve plus the buccal nerve 
with 3.6 mL of either articaine with epinephrine or 
prilocaine with felypressin. A second 10-mL blood 
sample was collected 5 minutes after injecting the anes-
thetic (t5´). Surgery was carried out immediately there-
after, always by the same maxillofacial surgeon using 
the standard procedure: surrounding flap, ostectomy, 
odontosection, extraction and suture (7). The surgical 
time was measured from the moment of the first inci-
sion until the last suture was cut (x=7.56 min; SD=1.98). 
In all cases, the surgery took less than 15 minutes, no 
patients complained of pain, and there were no cases 
of neurologic injury. Once surgery had been completed, 
the patient remained in the chair in a supine position, 
whilst two further 10-mL blood samples were extracted 
at 60 (t60´) and 120 (t120´) minutes from commencing 
infiltration of the anesthetic. 
Though participants in the CG underwent neither an-
esthesia nor lower third molar extractions, 10-mL blood 
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samples were collected at t0 ,´ t5 ,´ t60´ and t120 ,´ under 
the same environmental conditions, and this was done 
on two days a fortnight apart (day 1 and day 2). 
Plasma was extracted from the blood samples by cen-
trifugation (Beckman model TJ-6 centrifuge). Subse-
quently, 50 mL of sodium metabisulphite (50 mg/mL) 
was added to the plasma and the mixture was separated 
into five vials per sample (0.75- mL MICRO vials Free-
zly, SIGMA). The samples were stored in liquid nitro-
gen, until analysis.
The p-MHPG and p-HVA levels were measured using 
high-pressure liquid chromatography coupled with cou-
lometric detection (8), while p-cortisol and p-prolactin 
levels were determined by a radioimmunoassay proce-
dure (Diagnostic Product Corporation).
Statistical analysis was performed using Statgraphics 
Centurion XVI. The sample size was not based on for-
mal power calculations. The mean variations in each of 
the groups in plasma levels of the markers at the four 
time points (t0 ,´ t5 ,´ t60´ and t120´) were studied with 
analysis of variance, the Kruskall-Wallis test and the 
multiple range test (MRT). Further, variations between 
the groups in the marker plasma levels at the same time 
points were studied using the Student’s t-test, analysis 
of variance, the multiple range test and signed range test 
(SRT). Test for related samples were used as data were 
not independent. The level of significance was pre-set 
at 0.05. 
t0´ t5´ t60´ t120´ 
Experimental group Articaine  with epinephrine 10.16±3.24 9.90±3.28 8.56±2.58 7.55±0.97a
Prilocaine with felypressin 10.05±2.71 9.50±2.70 8.15±2.55 7.33±2.02 a
Control group   Day 1 10.54±4.09 9.57±3.76 8.48±2.42 7.20±2.33 a
Day 2 10.39±4.19 9.67±3.56 7.68±2.27 7.00±2.02 a
Table 1. Mean plasma levels of homovanillic acid.
Plasma HVA levels (ng/mL; mean+SD) in samples collected a fortnight apart, before (t0’), and 5, 60 and 120 minutes after administration of 
the anesthetic  solution (t5’, t60’, t120’) in the experimental group and at the same times but without anesthesia in the control group.
a Significant reduction within all groups from t0’ to t120’ (MRT, p<0.05).
Table 2. Mean plasma levels of 3-methoxy-4-hydroxyphenylglycol.
Plasma MHPG levels (ng/mL; mean+SD) in samples collected a fortnight apart, before (t0’), and 5, 60 and 120 minutes after administration 
of the anesthetic solution (t5’, t60’, t120’) in the experimental group and at the same times but without anesthesia in the control group.
No significant differences found within or between the groups.
t0’ t5’ t60’ t120’ 
Experimental group  Articaine  with epinephrine 3.19±1.00 3.36±0.87 3.01±0.84 2.79±0.41 
Prilocaine  with felypressin 2.91±0.70 3.00±0.70 2.93±0.71 2.74±0.63 
Control group  Day 1 2.85±0.41 2.82±0.50 2.97±0.46 3.11±0.55 
Day 2 2.95±0.44 2.84±0.53 2.99±0.45 3.12±0.47 
Results
The mean and standard deviation of the plasma con-
centration of the four stress markers are summarized 
in tables 1 to 4.
A significant reduction in p-HVA levels was observed 
in all the subgroups as time passed (Table 1; MRT, 
p<0.05). There were, however, no significant differences 
in the mean p-HVA levels at any of the time points be-
tween the experimental and control groups, or between 
the two experimental subgroups in which different an-
esthetic/vasoconstrictor combinations were used.
Regarding p-MHPG levels (Table 2), there were no sig-
nificant differences within or between the groups at any 
time, rather the levels of this marker seemed to remain 
fairly stable in each individual throughout. Further, the 
p-MHPG levels did not correlate with those of the p-
HVA. 
Similarly, there were no significant differences in p-
prolactin levels at any time, either within or between the 
groups (Table 3). It must, however, be borne in mind the 
participants were healthy males, with very low values, 
close to the limits of detection of the technique used.
Lastly, we observed a trend for p-cortisol levels to 
fall in all the groups over time (Table 4). Comparing 
the groups, there were significant differences between 
the experimental and control groups at t0 ,´ t5´ and t60´ 
(MRT, p<0.05), though not at t120 .´ Further, comparing 
p-cortisol levels between the two subgroups in which 
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Table 3. Mean plasma levels of prolactin.
Plasma prolactin levels (ng/mL; mean+SD) in samples collected a fortnight apart, before (t0’), and 5, 60 and 120 minutes after administration 
of the anesthetic solution (t5’, t60’, t120’) in the experimental group and at the same times but without anesthesia in the control group.
No significant differences found within or between the groups.
Table 4. Mean plasma levels of cortisol.
Plasma cortisol levels (ng/dL; mean+SD) in samples obtained a fortnight apart, before (t0’), and 5, 60 and 120 minutes after administration of 
the anesthetic solutions (t5’, t60’, t120’) in the experimental group and at the same times but without anesthesia in the control group.
a Significant differences from t0’ to t120’ within all groups (MTR p<0.05).
b Significant differences at t60’ between the two anesthetic-vasoconstrictor combinations (SRT p<0.0007).
c Significant differences between the control group and the two experimental treatments at t0’, t5’ and t60’ (MRT, p<0.05).
t0´ t5´ t60´ t120´ 
Experimental group Articaine  with epinephrine 5.91±3.91 6.00±4.00 4.23±3.10 5.81±2.48 
Prilocaine  with felypressin 6.26±3.99 7.09±5.35 5.91±4.97 6.25±2.17 
Control group  Day 1 8.00±2.11 7.00±2.12 5.50±2.40 5.47±1.85 
Day 2 7.90±3.09 6.50±6.90 5.40±2.13 5.37±1.87 
t0´ t5´ t60´ t120´ 
Experimental group  Articaine  with epinephrine 20.50±5.53 c 21.46±5.99 c 15.95±6.63 b c 10.36±3.64 a
Prilocaine  with felypressin 21.17±5.28 c 20.65±6.33 c 21.04±6.77b c 13.41±5.68 a
Control group  Day 1 17.30±3.87 c 14.93±3.50 c 11.20±4.02 c 11.45±5.98 a
Day 2 17.40±3.86 c 14.97±3.75 c 11.10±3.89 c 11.45±5.78 a
different anesthetic/vasoconstrictor combinations were 
used, the mean values were significantly higher at t60´ 
in the group receiving prilocaine as anesthesia (signed 
rank test, p<0.001). The same trend persisted at t120 ,´ al-
though at this point the difference was not significant.
 
Discussion
The variations in levels of p-HVA, p-MHPG and p-
prolactin observed in this study did not differ signifi-
cantly between the control and experimental groups. On 
the other hand, the variations in plasma cortisol were 
significantly different, the level being higher in the ex-
perimental than the control group at all the time points 
studied (t0, t5, t60 and t120´). Further, the anesthetic/
vasoconstrictor combination used for the regional block 
influenced cortisol: levels were higher in patients given 
3% prilocaine with 1:1.850,000 felypressin, which cor-
responds clinically to higher levels of stress when this 
combination is used. 
Millions of dental interventions are carried out every 
day across the world using vasoconstrictors in combina-
tion with anesthetics. Though it is known that these in-
terventions cause stress, little is known about how this 
stress is affected by different anesthetic approaches. 
Hence, we set out to explore whether anesthetics with 
vasopressors affected patient stress levels and, if so, 
whether the effect was the same with all anesthetics. 
For this, we considered the extraction of impacted in-
ferior third molars under regional anesthesia, namely 
inferior alveolar nerve block. This surgical procedure is 
reproducible and has been used previously as a research 
model to assess the efficacy of drugs (9), hemodynamic 
changes (10) and stress markers (11). 
The main purpose of the split-mouth design is to con-
trol for all confounding factors related to differences 
between subjects by making within-patient compari-
sons, rather than between-patient comparisons; in this 
way, the experimental error variance can be reduced, 
and this means a statistically more powerful study. Un-
fortunately, comparisons made on a within-patient basis 
also have potential disadvantages. For this reason, we 
included a control group in which no treatment was car-
ried out to analyze variation in the markers.
Human response to surgical stress is characterized by 
a massive release of neuroendocrine hormones provok-
ing many metabolic and physiological changes (4). To 
explore a range of these changes, we studied four mark-
ers that have previously been associated with various 
situations of stress: p-cortisol, p-prolactin, p-HVA and 
p-MHPG (2-6). 
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The circadian rhythm of p-cortisol and p-prolactin are 
well known. Further, it has been demonstrated (12) that 
p-HVA levels tend to fall over the course of the morn-
ing. Our methodology allowed for these patterns since 
the study, in both the experimental and control groups, 
started at 8.30 a.m.  Furthermore, our model com-
menced in a maximum stress situation, which converts 
to one of rest, once surgery is over. This is a key char-
acteristic of the study, other authors studying the stress 
response having initiated the experiment in a rest situ-
ation and subsequently provoked stress over the course 
of the morning (3). 
In our research, we decided to study these stress mark-
ers in plasma, as we believe that the measurements are 
more accurate than in urine, saliva or tears (11). We rec-
ognize, however, that venipuncture in itself could be a 
source of stress. If this were to be the case, our design 
minimizes the possible associated bias, as experimental 
and control groups are subjected to the same blood col-
lection procedure. On the other hand, to minimize the 
stress potentially caused we decided to use the Vacu-
tainer® technique, as this meant that only one puncture 
was required to collect the four blood samples. We are 
unable to confirm the hypothesis of Grayson et al. (13) 
that an increase in p-prolactin and p-HVA levels is ob-
served in association with the stress of venipuncture, 
as independent of any intervention the levels of these 
markers in blood peak in the early hours of the morning 
and progressively decrease throughout the day, due to 
the circadian rhythm (5, 12). 
The absence of significant differences in the concentra-
tions of p-HVA between the experimental and control 
groups indicates that the surgical procedure has no im-
pact on this marker. The norepinephrine metabolite, p-
MHPG, had a stable concentration throughout the time 
period in all the groups; nevertheless, its concentration 
was slightly higher at t5´ and t60´ in the group admin-
istered articaine with epinephrine. These results are 
consistent with data from other authors affirming that 
p-MHPG variations are not attributable to the circadian 
rhythm (14). No significant differences were observed 
within or between groups when using catecholamine or 
vasopressin analogues as a vasoconstrictor. 
As was to be expected, p-cortisol levels did vary, show-
ing a significant reduction in concentration over time, 
both in control and experimental groups. There were, 
however, significant differences between the groups, 
with higher concentrations in the experimental groups 
than the controls. Indeed, the data suggest that p-cor-
tisol in the experimental groups was influenced by the 
stress associated with the surgical procedure. Further, 
the significant increase in p-cortisol at 60 minutes in 
those given prilocaine with felypressin (Table 4) sug-
gests that this group had clinically higher levels of stress 
throughout the study period than those given articaine 
with epinephrine. These results confirm previous find-
ings (6).  
In certain circumstances, the prolactin hormone under 
dopaminergic control may be a stress indicator. Fur-
ther, p-prolactin levels have been reported to increase 
in stressful situations (5); nevertheless, our results have 
not enabled us to confirm these previous findings. In 
the experimental groups, plasma levels at t0´ were lower 
than those in the control group. There was a slight in-
crease at t5´ in the experimental groups, this being more 
pronounced in the articaine group. Subsequently, levels 
fell in all the groups throughout the study period. This 
longer-term trend, which was more pronounced in the 
controls, may be due to the circadian rhythm and asso-
ciated decrease in plasma levels throughout the morn-
ing. One of the limitations in the analysis of prolactin is 
due to its plasma concentrations being on the technical 
limits of detection, all participants being men. We chose 
to limit the study to men to avoid the confounding vari-
able of sex. Furthermore, there is wide range of values, 
particularly in the experimental groups, as reflected in 
the large SD.
The types of local anesthetics used in our study, one 
group receiving epinephrine and the other felypressin, 
were not seen to produce any differences in the markers 
studied, except in the case of p-cortisol that was lower 
in the epinephrine group at t60 .´
In conclusion, firstly, in a healthy young population, the 
stress generated by lower third molar exodontias causes 
variations in p-cortisol levels, the best plasma marker 
of stress, but not in the other markers studied, namely 
p-HVA, p-MHPG and p-prolactin. Secondly, the use of 
articaine with epinephrine is associated with a smaller 
increase in cortisol levels, corresponding clinically to a 
lower level of stress. The effect of different anesthetic-
vasoconstrictor combinations on stress should be con-
sidered in deciding which anesthetic approach to use. 
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